SCHEMBL18201073

SCHEMBL18201073

Cc1ccc(-c2nc(-c3ccc(C)cc3)nc(-c3ccnc(-c4nc5ccccc5c5c4ccc4ccccc45)c3)n2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 3/20 0.43
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
HTT P42858 2/20 0.43
XBP1 P17861 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
CYP1A2 P05177 2/20 0.41
CYP1A1 P04798 1/20 0.41
CYP1B1 Q16678 1/20 0.41
ALDH1A1 P00352 5/20 0.40
MAPT P10636 5/20 0.40
KDM4E B2RXH2 4/20 0.40
CYP3A4 P08684 1/20 0.40
HPGD P15428 1/20 0.40
MAPK1 P28482 1/20 0.40
CASP1 P29466 1/20 0.40
CYP2C19 P33261 1/20 0.40
CASP7 P55210 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
HSD17B10 Q99714 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18200724 0.92 MAPT (0.41) ATMNPC1RAB9ANPSR1ALDH1A1
SCHEMBL18201064 0.90 KDM4E (0.45) NPC1RAB9ACYP1A2ALDH1A1MAPT
SCHEMBL18201051 0.90 KDM4E (0.38) ATMNPSR1ALDH1A1MAPTKDM4E
SCHEMBL18201058 0.86 METAP1 (0.44) NPC1RAB9ANPSR1ALDH1A1MAPT
SCHEMBL18200720 0.86 MAPT (0.46) NPC1RAB9AALDH1A1MAPTKDM4E
SCHEMBL18201057 0.85 KDM4E (0.39) ATMNPC1RAB9ACYP1A2ALDH1A1
SCHEMBL18201239 0.85 MAPT (0.44) ATMNPC1RAB9ACYP1A1CYP1B1
SCHEMBL18201236 0.85 MAPT (0.44) ATMNPC1RAB9ACYP1A1CYP1B1
SCHEMBL18347003 0.85 MAPT (0.44) ATMNPC1RAB9ACYP1A1CYP1B1
SCHEMBL18347002 0.85 MAPT (0.45) ATMNPC1RAB9ACYP1A1CYP1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9728731-B2 Heterocyclic compound and organic light emitting device using same HEESUNG MATERIAL LTD. (KR) 2017-08-08 US disclosed
US-9728731-B2 Heterocyclic compound and organic light emitting device using same HEESUNG MATERIAL LTD. (KR) 2017-08-08 US disclosed
US-20160380208-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME HEESUNG MATERIAL LTD. (KR) 2016-12-29 US disclosed
EP-3088392-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME Heesung Material Ltd. (KR) 2016-11-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160380208-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME NOTUM, DDT, CRY1 ATM 2923/4885NPC1 3875/4885RAB9A 2864/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.